英文别名:
Adenosine5'-(trihydrogen diphosphate), P'®dihydronicotinamide-adenine dinucleotide;Reduced nicotinamide-adenine dinucleotide;5'-ester with 1,4-dihydro-1-b-D-ribofuranosyl-3-pyridinecarboxamide; β-
NADH; β-DPNH; Reduced nicotinamide-adenine dinucleotide (NADH); Reduced nicotinamide-adenine dinucleotide; Reduced
nicotinamide adenine diphosphate; Reduced diphosphopyridine nucleotide; Reduced codehydrogenase I; Nicotinamide-adenine dinucleotide, reduced; Nicotinamide adenine dinucleotide
2
(reduced form); NADH ; N 8129; ENADA; Dihydronicotinamide mononucleotide;
Dihydronicotinamide adenine dinucleotide; Dihydrocozymase; Dihydrocodehydrogenase I; DPNH; Cozymase I, reduced; Coenzyme I, reduced; Codehydrogenase I, reduced; Codehydrase I,
reduced; 1,4-Dihydronicotinamide adenine dinucleotide; Adenosine
pyrophosphate, 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (7CI);Adenosine 5'-(trihydrogen pyrophosphate), 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (8CI);Adenosine 5'-(trihydrogen diphosphate), P'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinecarboxamide;Coenzyme I, reduced;NAD-reduced;dihydrodiphosphopyridine nucleotide;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate;nadh hydride;Codehydrogenase I, reduced;bmse000054;C00004;NADH;Adenosine pyrophosphate, 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (7CI);CHEBI:16908;Adenosine 5'-(trihydrogen pyrophosphate), 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (8CI);D0B8SV;Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt;SCHEMBL8187;CHEMBL1234616;nicotinamide adenine dinucleotide (reduced);NADH [WHO-DD];Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;4J24DQ0916;dihydronicotinamide adenine dinucleotide;Adenosine 5'-(trihydrogen diphosphate), 5'->'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;DB00157;Dihydrocozymase;Adenosine 5'-(trihydrogen diphosphate), 5'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt;1,4-Dihydronicotinamide adenine dinucleotide;Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;DPNH;UNII-4J24DQ0916;606-68-8;Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;NADH2;Nicotinaminde-Adenine-Dinucleotide;Q26987453;Reduced Nicotinamide Adenine Dinucleotide;beta-NADH;[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate;diphosphopyridine nucleotide reduced;C21H29N7O14P2;Nicotinamide adenine dinucleotide, reduced form;ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), P'->5'-ESTER WITH 1,4-DIHYDRO-1-.BETA.-D-RIBOFURANOSYL-3-PYRIDINECARBOXAMIDE;Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide (9CI);b-NADH;Dihydronicotinamide mononucleotide;Nicotinamide-adenine dinucleotide, reduced;C21-H29-N7-O14-P2.2Na;C21-H29-N7-O14-P2;[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-phosphinic acid;EINECS 200-393-0;b-dpnh;coenzyme-I;adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}; cent-dpnh;Codehydrase I, reduced;Reduced codehydrogenase I;Nicotinamide - adenine dinucleotide, reduced;beta-DPNH;BOPGDPNILDQYTO-NNYOXOHSSA-N;Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with 1,4-dihydro-1beta-D-ribofuranosylnicotinamide;Adenosine 5'-(trihydrogen diphosphate), P'-->5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;EN300-19742425;[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate;58-68-4;NADH+H+;NAD REDUCED FORM [MI];[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid;Dihydrocodehydrogenase I;Cozymase I, reduced;DTXSID30889320;GTPL4487;NAD reduced form;Adenosine 5'-(trihydrogen diphosphate), 5'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;ENADA;Diphosphopyridine nucleotide,reduced form;Reduced diphosphopyridine nucleotide;C21H29N7O14P2.2Na;Reduced nicotinamide adenine diphosphate;Adenosine 5'-(trihydrogen diphosphate), P'?5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt;adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate};Adenosine pyrophosphate, 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (7CI);N 8129;Nicotinamide adenine dinucleotide (reduced form);Reduced nicotinamide-adenine dinucleotide (NADH);β-DPNH;β-NADH;((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid;NADH dianion;BRD-A84188517-304-01-1;Adenosine 5'-(trihydrogen diphosphate), P'a5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;HY-113355;CS-0062281;
Inchi:
1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1